Clinical Trial Update: Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin [Phase 2]

View source ↗

Summary

A completed Phase 2 study evaluated potential drug-drug interactions between valopicitabine and ribavirin in patients with chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)
• Valopicitabine (valopicitabine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED